Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Single-cell epigenomics uncovers heterochromatin instability and transcription factor dysfunction during mouse brain aging.
PMID 41824460 · PMC13189690 · Cell reports · 2026 · 8 claims · 6 setups
Aging causes widespread, concordant changes in chromatin accessibility and gene expression across neuronal and glial cell types in the mouse brain
-
Full-text index only
Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traits.
PMID 41826324 · PMC13139607 · Nature communications · 2026 · 8 claims · 8 setups
T1D GWAS heritability is enriched in accessible chromatin of brain-resident cells, most notably microglia, across neurodevelopment into adulthood
-
Full-text index only
Single-nucleus multiomic profiling of the aging mouse substantia nigra reveals conserved gene alterations linked to Parkinson's disease.
PMID 41781332 · PMC13138337 · Genome research · 2026 · 8 claims · 7 setups
Single-nucleus multiome (RNA+ATAC) sequencing of mouse substantia nigra across four age stages (2, 6, 12, 18 months) yields a 40,125-cell atlas spanning 27 cell subclasses
-
Full-text index only
Dominant clones leverage developmental epigenomic states to drive ependymoma.
PMID 41882368 · PMC13102692 · Nature · 2026 · 8 claims · 8 setups
Chromatin accessibility patterns in neural progenitor cells are pre-established during normal development and are subsequently commissioned (not created) by ZR binding to drive oncogene expression
-
Full-text index only
A unique malignant cell type per patient tumor encoded in each cancer cell transcriptome.
PMID 41884004 · PMC13010111 · iScience · 2026 · 8 claims · 8 setups
Malignant cells cluster predominantly by tumor of origin, while non-malignant cells from the same tumors cluster by cell type independent of patient